No. 9 Eli Lilly, USA (NYSE:LLY)
Revenue: $23.1 billion
Eli Lilly & Co., with a market cap of $77.43 billion, develops and sells pharmaceutical products for humans and animals. The company was founded in 1876 and is headquartered in Indianapolis. Eli Lilly & Co., currently has about 38,000 employees in 125 countries.